Mary Stevens, MD
Sleep Medicine · Overland Park, KSNPI 1811931231
Payments from drug & device makers
Across 367 payments — averaging $443.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$78K
- Inspire Medical Systems, Inc.$48K
- Harmony Biosciences LLC$36K
- Ironshore Pharmaceuticals Inc.$257
- Axsome Therapeutics, Inc.$194
- Avadel CNS Pharmaceuticals, LLC$148
- plus $539 from 10 others
What the payments were for
- Consulting fees$46,03729%
- Speaking & faculty fees$89,87258%
- Travel & lodging$11,2667%
- Food & beverage$8,4055%
- Education$5770%
- Gifts$290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 123 | $77,957 |
| Inspire Medical Systems, Inc. | 47 | $47,568 |
| Harmony Biosciences LLC | 146 | $36,239 |
| Ironshore Pharmaceuticals Inc. | 10 | $257 |
| Axsome Therapeutics, Inc. | 9 | $194 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $148 |
| Azurity Pharmaceuticals, Inc. | 9 | $146 |
| Tris Pharma Inc | 1 | $125 |
| Arbor Pharmaceuticals, Inc. | 7 | $89 |
| Idorsia Pharmaceuticals US Inc | 4 | $69 |
| Resmed Corp | 2 | $45 |
| Corium, LLC | 2 | $19 |
| GRT US Holding, Inc. | 1 | $16 |
| Noven Therapeutics, LLC | 1 | $14 |
| Philips North America LLC | 1 | $13 |
| Medline Industries LP | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XYWAV$53,728
- Wakix$34,627
- Inspire$25,768
- SUNOSI$15,127
- Inspire Upper Airway Stimulation System$14,594
- XYREM$6,718
- Dyanavel XR$125
- Quillivant$125
- Quillichew ER$125
- JORNAY PM$122
- LUMRYZ$107
How this compares
Too few sleep medicine providers in Kansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 65 | $1,278,297 |
| WakixPitolisant Hcl | 65 | $919,892 |
| NeuproRotigotine | 24 | $25,253 |
| SunosiSolriamfetol Hcl | 13 | $24,038 |
| Modafinil | 40 | $20,252 |
| VyvanseLisdexamfetamine Dimesylate | 28 | $13,927 |
| HorizantGabapentin Enacarbil | 12 | $6,400 |
| Armodafinil | 85 | $5,934 |
| BelsomraSuvorexant | 13 | $5,653 |
| Lisdexamfetamine Dimesylate | 12 | $3,551 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 49 | $3,391 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 78 | $3,315 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 27 | $2,539 |
| Zaleplon | 83 | $2,216 |
| Methylphenidate Hcl | 50 | $2,119 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Harmony Biosciences LLCWakix | $36,239 | $919,89265 claims |
| Axsome Therapeutics, Inc.Sunosi | $194 | $24,03813 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $89 | $6,40012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few sleep medicine providers in Kansason file to place this against a meaningful peer group, so we don't.
Other sleep medicine in Overland Park
- David CocanowerOverland Park$2K
- Saurav LuthraKansas City$5K
- Hugh WongWichita$2K
- Alan Gonzalez ZapataTopeka$2K
- Asjad SalmanKansas City$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.